0001656472-24-000037.txt : 20240319 0001656472-24-000037.hdr.sgml : 20240319 20240319170220 ACCESSION NUMBER: 0001656472-24-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240315 FILED AS OF DATE: 20240319 DATE AS OF CHANGE: 20240319 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: GORENSTEIN MICHAEL RYAN CENTRAL INDEX KEY: 0001797199 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38403 FILM NUMBER: 24764773 MAIL ADDRESS: STREET 1: 111 PETER STREET, SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cronos Group Inc. CENTRAL INDEX KEY: 0001656472 STANDARD INDUSTRIAL CLASSIFICATION: MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 STATE OF INCORPORATION: A6 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 BUSINESS PHONE: (416) 504-0004 MAIL ADDRESS: STREET 1: 111 PETER STREET STREET 2: SUITE 300 CITY: TORONTO STATE: A6 ZIP: M5V 2H1 FORMER COMPANY: FORMER CONFORMED NAME: PharmaCan Capital Corp. DATE OF NAME CHANGE: 20151021 4 1 wk-form4_1710882126.xml FORM 4 X0508 4 2024-03-15 0 0001656472 Cronos Group Inc. CRON 0001797199 GORENSTEIN MICHAEL RYAN 111 PETER STREET, SUITE 300 TORONTO A6 M5V 2H1 ONTARIO, CANADA 1 1 0 0 See remarks below 0 COMMON SHARES 2024-03-15 4 M 0 31361 0 A 9859538 D COMMON SHARES 2024-03-15 4 F 0 7636 1.98 D 9851902 D COMMON SHARES 2024-03-15 4 M 0 324539 0 A 10176441 D COMMON SHARES 2024-03-15 4 F 0 79025 1.98 D 10097416 D RESTRICTED STOCK UNITS 2024-03-15 4 M 0 31361 0 D COMMON SHARES 31361 5321715 D RESTRICTED STOCK UNITS 2024-03-15 4 M 0 324539 0 D COMMON SHARES 324539 4997176 D Each restricted stock unit ("RSU") represents a contingent right to receive one common share of Cronos Group Inc. On August 5, 2022, the reporting person was granted 94,083 RSUs, vesting in three substantially equal installments on each of March 15, 2023, March 15, 2024 and March 15, 2025. On March 15, 2023, the reporting person was granted 973,618 RSUs, vesting in three substantially equal annual installments beginning on the first anniversary of the grant date. Chairman, Chief Executive Officer, and President /s/ Aaron Werner, as attorney-in-fact for Michael R. Gorenstein 2024-03-19